Researchers are particularly encouraged by new data involving a personalized mRNA therapy developed by Moderna and Merck.

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...

A personalized mRNA cancer vaccine developed by Moderna and Merck — when combined with the immunotherapy drug Keytruda — ...

The battle against the most dangerous type of skin cancer has made a huge leap forward, and it could dramatically change the ...

Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown ...

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

A new treatment platform developed by researchers at the University of Texas MD Anderson Cancer Center was able to deliver ...

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...

Many of the deadliest forms of cancer are caused by a pathological mutation in the RAS protein. Yet, to date, no effective ...

Although Moderna has outperformed the broader health care sector over the last 12 months, analysts maintain a cautious stance ...